Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in PTSD
NCT00203463Phase 4Completed
- Sponsor
- Tuscaloosa Research and Education Advancement Corporation
- Start
- Jul 2001
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of topiramate in post-traumatic stress disorder (PTSD), sponsored by Tuscaloosa Research and Education Advancement Corporation. Started Jul 2001; status: completed.
02
Drugs
topiramate
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00203463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203463.